Literature DB >> 10722244

Discordance between pre and post cardiac transplant diagnosis: implications for pre- and postoperative decision making.

A Angelini1, G M Boffa, U Livi, A Barchitta, D Casarotto, G Thiene.   

Abstract

A correct clinical diagnosis in end-stage patients undergoing cardiac transplantation may have important prognostic and therapeutic implications. A retrospective clinico-pathologic study was carried out in 257 patients who had undergone cardiac transplantation at the University of Padua. A discrepancy between clinical and pathological diagnosis was found in 20 cases (8%). Among 126 patients with the clinical diagnosis of dilated cardiomyopathy, seven were found eventually to have ischemic heart disease (IHD), five myocarditis, one arrhythmogenic right ventricular cardiomyopathy (ARVC), and one non-compacted myocardium. Among the 87 patients with clinical diagnosis of IHD, three turned out to be dilated cardiomyopathy and one granulomatous myocarditis. Among the 10 patients with the clinical diagnosis of hypertrophic-restrictive cardiomyopathy, one had ARVC and one had cardiac fibroma. Altogether, only 24.5% underwent endomyocardial biopsy (EMB) and 75% coronary angiography before transplantation. Missed diagnosis of myocarditis occurred in patients in whom EMB was not carried out. EMB and coronary angiography might be indicated routinely in patients with apparent dilated cardiomyopathy, before proceeding to cardiectomy.

Entities:  

Mesh:

Year:  1999        PMID: 10722244     DOI: 10.1016/s1054-8807(98)00026-x

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  7 in total

Review 1.  Diagnostic use of the endomyocardial biopsy: a consensus statement.

Authors:  Gaetano Thiene; Patrick Bruneval; John Veinot; Ornella Leone
Journal:  Virchows Arch       Date:  2013-06-08       Impact factor: 4.064

2.  Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy.

Authors:  Lutz Frankenstein; Henrik Hees; Tobias Taeger; Hanna Froehlich; Andreas Dösch; Rita Cebola; Christian Zugck; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2013-06-26       Impact factor: 5.460

3.  The discrepancies between clinical and histopathological diagnoses of cardiomyopathies in patients with stage D heart failure undergoing heart transplantation.

Authors:  Thana Lertsuttimetta; Monravee Tumkosit; Peerapat Kaveevorayan; Poonchavist Chantranuwatana; Nonthikorn Theerasuwipakorn; Pairoj Chattranukulchai; Sarinya Puwanant
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

4.  Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy.

Authors:  Adriana Luk; Mohammed Metawee; Eric Ahn; F Gustafsson; Heather Ross; Jagdish Butany
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

5.  Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnoses.

Authors:  William C Roberts; Carey Camille Roberts; Jong Mi Ko; Giovanni Filardo; John Edward Capehart; Shelley Anne Hall
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

6.  Evaluation of cardiomyopathy diagnosis in heart transplant recipients: comparison of echocardiographic and pathologic classification.

Authors:  Neda Behzadnia; Babak Sharif-Kashani; Zargham Hossein Ahmadi; Farah Naghashzadeh; Atosa Dorudinia; Alireza Jahangirifard; Hamoun Hamarz; Payam Abbasi
Journal:  Egypt Heart J       Date:  2021-03-25

7.  Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation.

Authors:  Lucy Q Lin; Felipe Kazmirczak; Ko-Hsuan Amy Chen; Osama Okasha; Prabhjot S Nijjar; Cindy M Martin; Mehmet Akçakaya; Afshin Farzaneh-Far; Chetan Shenoy
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.